Trudexa/ methotrexat- kombinationsterapi var klinisk og statistisk bedre end methotrexat- monoterapi (p < 0, 001) og Trudexa- monoterapi (p < 0, 001) i opnåelsen af lav sygdomstilstand hos patienter med nylig diagnosticeret moderat til alvorlig reumatoid artrit.
Trudexa/ methotrexate combination therapy was clinically and statistically superior to methotrexate (p < 0.001) and Trudexa monotherapy (p < 0.001) in achieving a low disease state in patients with recently diagnosed moderate to severe no